|Institute for Research & Innovation|
- Institute for Research & Innovation
- About Us
- Participate in a Study
- Become an Investigator
- Information for Sponsors
Heart ValveTitle: Clinical Trial of the On-X® Valve Using Low Dose Anticoagulation Purpose: This study includes patients who will have their diseased heart valve replaced with the On-X mechanical heart valve. It is being done to determine whether lower levels of anticoagulation, including lower INR on Warfarin as well as Aspirin + Plavix only, can be used to prevent clotting events in patients who receive this particular mechanical heart valve.
To learn more about the On-X® Valve, click here.
Who Can Participate?
Diagnosis or Condition: Patients undergoing an aortic or mitral heart valve replacement
Age: 18 yrs or older
Sex: Males and Females
Visits: Yearly visits for up to 8 years. (4 visits the first year). Home INR meter management for patients on Coumadin
Study Coordinator: Meredith (Janey) Barnhart 253-403-7258
For more information, contact the Study Coordinator and reference ON-X